Navigation Links
MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
Date:4/1/2008

SAN JOSE, Calif., April 1, 2008 /PRNewswire/ -- MAQUET Cardiovascular LLC today announced that it filed concurrent patent infringement complaints in the United States International Trade Commission and the U.S. District Court for the District of Northern California against Terumo Corporation and Terumo Cardiovascular Systems Corporation. The complaints allege that Terumo infringes two MAQUET U.S. patents through the manufacture, use, sale, and/or importation of its VirtuoSaph(TM) endoscopic vessel harvesting (EVH) system. The ITC case seeks to exclude the infringing products from importation into the United States and the district court case seeks monetary damages and an injunction.

During heart bypass surgery, the surgeon removes part of a healthy blood vessel from the patient and uses it to create a new blood flow path in the heart. MAQUET Cardiovascular is the market leader in EVH with its VASOVIEW(R) products, which enable a cardiovascular surgeon to remove a patient's vessel less invasively, typically from the leg. EVH has been demonstrated to reduce wound complications, shorten hospital stays, and significantly minimize scarring compared to open harvesting techniques. EVH can help patients regain mobility more quickly, which contributes to their overall recovery and future heart health.

"MAQUET, and its predecessors, have pioneered eight generations of EVH products -- each built on our proprietary technology that delivers demonstrated efficacy, safety, and reliability," said Patrick T. Walsh, Executive Vice President and Chief Operating Officer of MAQUET Cardiovascular LLC. "As our patients rely on this technology for quicker recovery after heart bypass surgery, we must defend our intellectual property assets so that we can continue EVH innovation."

About MAQUET Cardiovascular

MAQUET Cardiovascular LLC is a division of MAQUET Medical Systems, part of the publicly listed Swedish group of companies GETINGE AB. MAQUET Cardiovasc
'/>"/>

SOURCE MAQUET Cardiovascular LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ARJO / Getinge / Maquet Announces New West Coast Showroom Opening
2. 2-drug blood pressure therapy lowers cardiovascular risk
3. Decreased sexual satisfaction is not associated with cardiovascular disease in postmenopausal women
4. Mary Matalin and John Ray Join the Cheney Cardiovascular Institute Board of Directors
5. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
6. Medical Simulation Corporation to Present Comprehensive Cardiac Patient Scenario at the Society for Cardiovascular Angiography and Interventions (SCAI) and American College of Cardiology (ACC) Conference
7. Study finds certain liver disease related to cardiovascular fitness
8. Randy Jackson and the American Heart Association Educate Raleigh Area Residents About the Connection Between Type 2 Diabetes and Cardiovascular Disease
9. Cardiovascular nursing: Striving for excellence in the care of cardiac patients
10. Glaucoma May Boost Cardiovascular Death Risk in Blacks
11. Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... December 26, 2014 The Biofeedback Federation ... March 24-28, 2015 in Rome, Italy and is hosted ... workshops on a wide variety of topics ... as peak performance training in athletes. The scientific program ... world. , Biofeedback monitoring allows clients to see what ...
(Date:12/26/2014)... PA (PRWEB) December 26, 2014 Pentec ... Work in the state of Pennsylvania for 2014. The ... first statewide programs of its kind in the country. ... Foundation, the Pennsylvania Department of Community and Economic Development, ... Resource Management and the Central Penn Business Journal. ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 This ... state of the global Sterilizers industry with a focus ... on the market status of the Sterilizers manufacturers and ... companies and individuals interested in the industry. This report ... definition, applications and manufacturing technology. In this part, the ...
(Date:12/25/2014)... New York (PRWEB) December 25, 2014 ... 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue ... reports. According to an Order issued in the U.S. ... the Court will convene an open conference on January ... and United States Courthouse in West Palm Beach, Florida. ...
(Date:12/25/2014)... The short film “Color of Honor” by young director/producer ... true 9/11 hero, Welles Remy Crowther. It has been chosen ... of Nuremberg International Short Film Festival and the 8th International ... and director Luciana Lagana plays the mother of the ... Gregory Graham - Graham plays a heroic policeman ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... Social Media Guru Mashable.com Cites Organizations Using Social Media for ... July 1 The Oral Cancer Foundation was recently praised ... discussing non-profit organizations that are effectively using Internet-based social media ... focused exclusively on Web 2.0 and social media such as ...
... Zufall Health Center, a federally qualified health center operating ... eco-friendly mobile medical unit. , , The Highlands ... to low-income, mostly uninsured residents of Hunterdon, Warren and ... at a ribbon cutting ceremony in Flemington. , ...
... transplantation offers a good chance for survival for patients ... factors are associated with worse outcomes. Patients who are ... children whose liver failure was caused by antiepileptic drugs ... are in the July issue of Liver Transplantation ...
... TeamHealth Demonstrates Ongoing Commitment to Patient Care through Patient ... 1 TeamHealth announced today that it has been ... On July 1, its patient safety organization -- the ... the Agency for Healthcare Research and Quality (AHRQ), the ...
... ... vivid personal stories about Internet dating and end-of-life dilemmas. Some stories will be used for ... Kenner. , ... 1, 2009 -- Kayce Freed Jennings, the wife of late ABC newsman Peter Jennings, and Marc ...
... what remains unclear , WEDNESDAY, July 1 (HealthDay News) -- ... more common in recent years, a new Mayo Clinic study ... issue of Gastroenterology , the disease is four times ... 1950s. In addition, the researchers found that the death rate ...
Cached Medicine News:Health News:Oral Cancer Foundation Praised for Its Social Media Efforts 2Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 2Health News:Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center 3Health News:Study examines liver transplantation after drug induced acute liver failure 2Health News:Study examines liver transplantation after drug induced acute liver failure 3Health News:TeamHealth Recognized by National Quality Agency 2Health News:TeamHealth Recognized by National Quality Agency 3Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 2Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 3Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 4Health News:Celiac Disease Making Inroads in U.S. 2
(Date:12/24/2014)... 2014  Novastem, a leader in regenerative medicine, ... its study for ischemic stroke at Clinica Santa ... strokes account for 87 percent of all stroke ... the study, entitled "Internal Research Protocol in Combination ... Cells and Intrathecal Administration of Neural Stem Cells ...
(Date:12/24/2014)... Pa. , Dec. 24, 2014  Commonwealth Cornerstone Group ... Markets Tax Credits transaction on Tuesday to help fund the ... Network (PHN) in Sharon . ... in Pennsylvania . It is the largest ... with more than 150 people on staff. Currently, ...
(Date:12/24/2014)... 24, 2014 Kinex Pharmaceuticals announced today that ... Roswell Park Cancer Institute. KX2-361 (KX02), a ... has shown potent inhibitory activity against a broad panel ... resistant to Temozolomide (T98G), the most widely used chemotherapy ... brain tumor mouse model, KX2-361 consistently clears brain tumors ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
... announces that a new market research report is ... Cardiac Defibrillators Industry http://www.reportlinker.com/p098394/Global-Cardiac-Defibrillators-Industry.html ... markets for Cardiac Defibrillators in Units and US$ ... analyzed by the following segments - Implantable/Internal Cardiac ...
... 24, 2011 Reportlinker.com announces that a new ... Global ECG Telemetry Devices Industry ... This report analyzes the worldwide markets for ... following Product Segments: Patient Digital Transmitters, Electrical Leads, ...
Cached Medicine Technology:Reportlinker Adds Global Cardiac Defibrillators Industry 2Reportlinker Adds Global ECG Telemetry Devices Industry 2
Enzymatic Clearance assay for the in vitro quantitative determination of HDL-cholesterol in human serum and plasma....
For the quantitative in vitro determination of Ammonia in plasma...
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: